GL
US EQUITY
Financials
Life & Health Insurance
CIK: 320335
Globe Life (GL) Quant Factor Diagnostic & Fair Value Model
Globe Life (Ticker: GL) is listed in the Financials sector (Life & Health Insurance). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$154.79
-8.09%
Latest Close (2026-10-23)
Market Cap: $144.71M
P/E Ratio: 10.6
Momentum Strength
3M / 12M
-11.23%
1M: -7.49%
12M: +14.13%
Quality (ROE)
Point-in-Time
+18.70%
Trailing Return on Equity
Technical Trend
RSI 14
31.5
SMA50: $170.06
SMA200: $159.30
Valuation Multiplier
Trailing
10.6
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
GL trades at an attractive earnings multiple of 10.6x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 320335 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $1.60B | $287.75M | $735.00M | $3.65 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $1.48B | $252.75M | $739.81M | $3.05 |
| 10-Q | 2026-03-31 | 2026-05-07 | $1.56B | $270.53M | $420.94M | $3.39 |
| 10-Q | 2025-03-31 | 2026-05-07 | $1.48B | $254.56M | $431.89M | $3.01 |
| 10-K | 2025-12-31 | 2026-02-25 | $5.99B | $1.16B | $1.40B | $14.07 |
| 10-K | 2024-12-31 | 2026-02-25 | $5.78B | $1.07B | $1.40B | $11.94 |
| 10-K | 2023-12-31 | 2026-02-25 | $1.42B | $274.80M | $1.48B | $2.88 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Globe Life (GL) valuation multiples, momentum factors, and point-in-time filing conventions.
How should GL's current valuation multiple be interpreted? ↓
GL trades at a trailing P/E of 10.6x within the Financials sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are GL's key momentum and technical factor indicators? ↓
As of the latest close, GL shows a 1-month return of -7.49%, 3-month return of -11.23%, and 12-month return of +14.13%, with a 14-day RSI of 31.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for GL? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can GL be incorporated into systematic factor models? ↓
GL can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.